Socioeconomic Evaluation of Drug Therapy

1. Front Matter

   Pages I-XV

   PDF

2. Opening Adress

   1. Opening Adress

      • B. Roos

      Pages 1-3

3. The Role of Economics in Drug Therapy

   1. Front Matter

      Pages 5-5

      PDF

   2. The Changing Economic Milieu in the United States

      • D. Neuhauser

      Pages 7-14

   3. The Economic Milieu in Europe: View of the Common Market

      • R. Hankin

      Pages 15-22

   4. The Economic Milieu in Europe: View of the Pharmaceutical Industry

      • D. Taylor

      Pages 23-31

   5. Pharmaceuticals and Decision-making in the United States: Cost Consciousness and the Changing Locus of Control

      • G. R. Wilensky, L. J. Blumberg, P. J. Neumann

      Pages 32-45

   6. What Price Pharmaceutical Innovation?

      • P. Zweifel

      Pages 46-59

   7. The Medical, Social, and Economic Implications of Disease

      • B. S. Bloom

      Pages 60-71

   8. From Medical to Socioeconomic Evaluation of Drug Therapy

      • J. L. Read

      Pages 72-81

   9. Discussion of Part I

      • Wilhelm van Eimeren, Bruno Horisberger

      Pages 82-84

4. Measuring the Effectiveness of Drug Therapy — The Economic Criteria

   1. Front Matter

      Pages 85-85

      PDF

   2. Cost-Effectiveness Study of Pharmaceuticals: Methodological Considerations

      • B. R. Luce

      Pages 87-94

   3. The Impact of Angina Pectoris on the Patient and the Influence of Treatment

      • S. H. Taylor

      Pages 95-100

   4. The Socioeconomic Study Program on Nitroderm TTS

      • P. Lauper

      Pages 101-109

   5. Cost — Cost Comparisons of Nitroderm TTS in Switzerland and Austria

      • R. H. Dinkel

      Pages 110-118

   6. The Cost-Effectiveness of Transdermal Nitroglycerin in the Michigan Medicaid Program: A Preliminary Report

      • D. M. Huse, G. Oster, B. A. Weisbrod, J. L. Read, B. L. Luce, A. M. Epstein

      Pages 119-131

   7. Cost-Benefit Analysis of Angina Prophylaxis in the Federal Republic of Germany

      • P. O. Oberender

      Pages 132-140

   8. Discussion of Part II

      • Wilhelm van Eimeren, Bruno Horisberger

      Pages 141-147

5. Measuring the Effectiveness of Drug Therapy — Social and Qualitative Criteria

   1. Front Matter

      Pages 149-149

      PDF

Modern drugs are invented according to medical needs, making use of the latest innovations in technology. They are sophisticated, efficacious, and costly, but are they effective? Are they superior to existing - and cheaper - alternatives, and is this superiority reflected in increased cost-effectiveness? Are they socially more beneficial? These questions, and those related to the intriguing search for better quality of life, are addressed in this book by experts from the fields of medicine, epidemiology, economics, sociology and the pharmaceutical industry. The book describes the environmental situation in the United States and Europe in which pharmaceutical development takes place; it also explores the grounds for agreement as well as disagreement between the social and the economic evaluations of progress. It tackles the problem of outcome measurements, patients' behavior, quality of life, and individual value judgments and describes methodological boundaries in the socioeconomic evaluation of drugs.

• Bevölkerungsmedizin
• Gesundheit
• Gesundheitswissenschaft
• Gesundheitswissenschaften
• Prävention
• Public Health
• drug
• economics
• heart
• locus of control
• medicine
• quality of life
• sociology
• therapy

• MEDIS, Neuherberg, Germany

  Wilhelm Eimeren

• Interdisciplinary Research Centre for Public Health, St. Gallen, Switzerland

  Bruno Horisberger

Policies and ethics